Disposition and metabolism of topically administered α-tocopherol acetate: A common ingredient of commercially available sunscreens and cosmetics

David S Alberts, Rayna Goldman, Min Jian Xu, Robert T Dorr, Jaime Quinn, Kevin Welch, José Guillen-Rodriguez, Mikel Aickin, Yei Mei Peng, Lois J Loescher, Helen Gensler

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Skin cancers are a serious health problem in the United States. One common method of skin cancer primary prevention is use of sunscreens. Research has been conducted to ascertain the role of active ingredients of sunscreen products in photoprotection and possible carcinogenesis. In contrast, little is known about the 'other ingredients,' listed or unlisted, on sunscreen product labels. One such ingredient is vitamin E, usually in the form of α-tocopherol acetate. Results of recent studies of skin carcinogenesis in an ultraviolet (UV) B mouse carcinogenesis model suggest that topically applied α-tocopherol acetate does not prevent and, under some conditions, enhances skin cancer development and growth, whereas the free unesterified form of α-tocopherol significantly reduces experimental UVB carcinogenesis. We have performed a Phase II cancer prevention study to evaluate whether topically applied α-tocopherol acetate is absorbed in human skin and metabolizes to the free or other forms. In this double-blind study, 19 men and women >30 years of age who had at least three actinic keratoses on their forearms were randomly assigned to apply α-tocopherol acetate (125 mg/g) or difluoromethylornithine cream to their arms twice daily for three months. Blood samples and photographs and punch biopsies of actinic keratoses were obtained before and at the end of the study (Month 4). Plasma and skin concentrations of free α-tocopherol, α-tocopherol acetate, and γ- tocopherol were analyzed by high-performance liquid chromatography at Month 4. The results of this report focus only on data obtained from the 11 participants randomized to the α-tocopherol acetate arm of the study. Topically applied α-tocopherol acetate was substantially absorbed in skin, with no evidence of conversion within skin to its unesterified form (i.e., free α-tocopherol). There was no evidence of systemic availability or biotransformation of topically applied α-tocopherol acetate. In summary, we have determined that α-tocopherol acetate is not metabolized to the free form of α-tocopherol in plasma or skin.

Original languageEnglish (US)
Pages (from-to)193-201
Number of pages9
JournalNutrition and Cancer
Volume26
Issue number2
StatePublished - 1996

Fingerprint

Sunscreening Agents
alpha-Tocopherol
cosmetics
tocopherols
Cosmetics
ingredients
acetates
Tocopherols
metabolism
skin (animal)
Skin
Carcinogenesis
Skin Neoplasms
Actinic Keratosis
carcinogenesis
hyperkeratosis
Arm
Eflornithine
sunscreens
ultraviolet radiation

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Oncology
  • Food Science

Cite this

Disposition and metabolism of topically administered α-tocopherol acetate : A common ingredient of commercially available sunscreens and cosmetics. / Alberts, David S; Goldman, Rayna; Xu, Min Jian; Dorr, Robert T; Quinn, Jaime; Welch, Kevin; Guillen-Rodriguez, José; Aickin, Mikel; Peng, Yei Mei; Loescher, Lois J; Gensler, Helen.

In: Nutrition and Cancer, Vol. 26, No. 2, 1996, p. 193-201.

Research output: Contribution to journalArticle

Alberts, DS, Goldman, R, Xu, MJ, Dorr, RT, Quinn, J, Welch, K, Guillen-Rodriguez, J, Aickin, M, Peng, YM, Loescher, LJ & Gensler, H 1996, 'Disposition and metabolism of topically administered α-tocopherol acetate: A common ingredient of commercially available sunscreens and cosmetics', Nutrition and Cancer, vol. 26, no. 2, pp. 193-201.
Alberts, David S ; Goldman, Rayna ; Xu, Min Jian ; Dorr, Robert T ; Quinn, Jaime ; Welch, Kevin ; Guillen-Rodriguez, José ; Aickin, Mikel ; Peng, Yei Mei ; Loescher, Lois J ; Gensler, Helen. / Disposition and metabolism of topically administered α-tocopherol acetate : A common ingredient of commercially available sunscreens and cosmetics. In: Nutrition and Cancer. 1996 ; Vol. 26, No. 2. pp. 193-201.
@article{f66137641b434c41b267dabde6bff797,
title = "Disposition and metabolism of topically administered α-tocopherol acetate: A common ingredient of commercially available sunscreens and cosmetics",
abstract = "Skin cancers are a serious health problem in the United States. One common method of skin cancer primary prevention is use of sunscreens. Research has been conducted to ascertain the role of active ingredients of sunscreen products in photoprotection and possible carcinogenesis. In contrast, little is known about the 'other ingredients,' listed or unlisted, on sunscreen product labels. One such ingredient is vitamin E, usually in the form of α-tocopherol acetate. Results of recent studies of skin carcinogenesis in an ultraviolet (UV) B mouse carcinogenesis model suggest that topically applied α-tocopherol acetate does not prevent and, under some conditions, enhances skin cancer development and growth, whereas the free unesterified form of α-tocopherol significantly reduces experimental UVB carcinogenesis. We have performed a Phase II cancer prevention study to evaluate whether topically applied α-tocopherol acetate is absorbed in human skin and metabolizes to the free or other forms. In this double-blind study, 19 men and women >30 years of age who had at least three actinic keratoses on their forearms were randomly assigned to apply α-tocopherol acetate (125 mg/g) or difluoromethylornithine cream to their arms twice daily for three months. Blood samples and photographs and punch biopsies of actinic keratoses were obtained before and at the end of the study (Month 4). Plasma and skin concentrations of free α-tocopherol, α-tocopherol acetate, and γ- tocopherol were analyzed by high-performance liquid chromatography at Month 4. The results of this report focus only on data obtained from the 11 participants randomized to the α-tocopherol acetate arm of the study. Topically applied α-tocopherol acetate was substantially absorbed in skin, with no evidence of conversion within skin to its unesterified form (i.e., free α-tocopherol). There was no evidence of systemic availability or biotransformation of topically applied α-tocopherol acetate. In summary, we have determined that α-tocopherol acetate is not metabolized to the free form of α-tocopherol in plasma or skin.",
author = "Alberts, {David S} and Rayna Goldman and Xu, {Min Jian} and Dorr, {Robert T} and Jaime Quinn and Kevin Welch and Jos{\'e} Guillen-Rodriguez and Mikel Aickin and Peng, {Yei Mei} and Loescher, {Lois J} and Helen Gensler",
year = "1996",
language = "English (US)",
volume = "26",
pages = "193--201",
journal = "Nutrition and Cancer",
issn = "0163-5581",
publisher = "Routledge",
number = "2",

}

TY - JOUR

T1 - Disposition and metabolism of topically administered α-tocopherol acetate

T2 - A common ingredient of commercially available sunscreens and cosmetics

AU - Alberts, David S

AU - Goldman, Rayna

AU - Xu, Min Jian

AU - Dorr, Robert T

AU - Quinn, Jaime

AU - Welch, Kevin

AU - Guillen-Rodriguez, José

AU - Aickin, Mikel

AU - Peng, Yei Mei

AU - Loescher, Lois J

AU - Gensler, Helen

PY - 1996

Y1 - 1996

N2 - Skin cancers are a serious health problem in the United States. One common method of skin cancer primary prevention is use of sunscreens. Research has been conducted to ascertain the role of active ingredients of sunscreen products in photoprotection and possible carcinogenesis. In contrast, little is known about the 'other ingredients,' listed or unlisted, on sunscreen product labels. One such ingredient is vitamin E, usually in the form of α-tocopherol acetate. Results of recent studies of skin carcinogenesis in an ultraviolet (UV) B mouse carcinogenesis model suggest that topically applied α-tocopherol acetate does not prevent and, under some conditions, enhances skin cancer development and growth, whereas the free unesterified form of α-tocopherol significantly reduces experimental UVB carcinogenesis. We have performed a Phase II cancer prevention study to evaluate whether topically applied α-tocopherol acetate is absorbed in human skin and metabolizes to the free or other forms. In this double-blind study, 19 men and women >30 years of age who had at least three actinic keratoses on their forearms were randomly assigned to apply α-tocopherol acetate (125 mg/g) or difluoromethylornithine cream to their arms twice daily for three months. Blood samples and photographs and punch biopsies of actinic keratoses were obtained before and at the end of the study (Month 4). Plasma and skin concentrations of free α-tocopherol, α-tocopherol acetate, and γ- tocopherol were analyzed by high-performance liquid chromatography at Month 4. The results of this report focus only on data obtained from the 11 participants randomized to the α-tocopherol acetate arm of the study. Topically applied α-tocopherol acetate was substantially absorbed in skin, with no evidence of conversion within skin to its unesterified form (i.e., free α-tocopherol). There was no evidence of systemic availability or biotransformation of topically applied α-tocopherol acetate. In summary, we have determined that α-tocopherol acetate is not metabolized to the free form of α-tocopherol in plasma or skin.

AB - Skin cancers are a serious health problem in the United States. One common method of skin cancer primary prevention is use of sunscreens. Research has been conducted to ascertain the role of active ingredients of sunscreen products in photoprotection and possible carcinogenesis. In contrast, little is known about the 'other ingredients,' listed or unlisted, on sunscreen product labels. One such ingredient is vitamin E, usually in the form of α-tocopherol acetate. Results of recent studies of skin carcinogenesis in an ultraviolet (UV) B mouse carcinogenesis model suggest that topically applied α-tocopherol acetate does not prevent and, under some conditions, enhances skin cancer development and growth, whereas the free unesterified form of α-tocopherol significantly reduces experimental UVB carcinogenesis. We have performed a Phase II cancer prevention study to evaluate whether topically applied α-tocopherol acetate is absorbed in human skin and metabolizes to the free or other forms. In this double-blind study, 19 men and women >30 years of age who had at least three actinic keratoses on their forearms were randomly assigned to apply α-tocopherol acetate (125 mg/g) or difluoromethylornithine cream to their arms twice daily for three months. Blood samples and photographs and punch biopsies of actinic keratoses were obtained before and at the end of the study (Month 4). Plasma and skin concentrations of free α-tocopherol, α-tocopherol acetate, and γ- tocopherol were analyzed by high-performance liquid chromatography at Month 4. The results of this report focus only on data obtained from the 11 participants randomized to the α-tocopherol acetate arm of the study. Topically applied α-tocopherol acetate was substantially absorbed in skin, with no evidence of conversion within skin to its unesterified form (i.e., free α-tocopherol). There was no evidence of systemic availability or biotransformation of topically applied α-tocopherol acetate. In summary, we have determined that α-tocopherol acetate is not metabolized to the free form of α-tocopherol in plasma or skin.

UR - http://www.scopus.com/inward/record.url?scp=0345367349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345367349&partnerID=8YFLogxK

M3 - Article

C2 - 8875556

AN - SCOPUS:0345367349

VL - 26

SP - 193

EP - 201

JO - Nutrition and Cancer

JF - Nutrition and Cancer

SN - 0163-5581

IS - 2

ER -